APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Anesthetics

Compare research editions
View pricing & licenses

Selected research

Industry Research

General Anesthetics Industry Research Report 2026

20 December 2025136 pages

Choose your research edition.

Industry ResearchGeneral Anesthetics Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal General Anesthetics Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal General Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Anesthetics Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal General Anesthetics Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global General Anesthetics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for General Anesthetics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for General Anesthetics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of General Anesthetics include Eisai, Johnson & Johnson, Merck, Jiangsu Hengrui Pharmaceutical Co., Ltd., GlaxoSmithKline, Fresenius Kabi AG, Baxter International, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global General Anesthetics market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

General Anesthetics Market by Company

Eisai

Johnson & Johnson

Merck

Jiangsu Hengrui Pharmaceutical Co., Ltd.

GlaxoSmithKline

Fresenius Kabi AG

Baxter International

AbbVie

AstraZeneca

Lannett

Hikma Pharmaceuticals

Endo International

Boehringer Ingelheim

B. Braun Melsungen AG

Aspen Pharmacare

Abbott Laboratories

General Anesthetics Segment by Type

Inhalation Anesthestic

Intravenous Anesthestic

General Anesthetics Segment by Application

Hospital

Ambulatory Surgery Center

Others

General Anesthetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of General Anesthetics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of General Anesthetics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of General Anesthetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global General Anesthetics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global General Anesthetics Sales (k units) of Manufacturers (2021-2026) Table 7. Global General Anesthetics Sales Market Share by Manufacturers (2021-2026) Table 8. Global General Anesthetics Revenue of Manufacturers (2021-2026) Table 9. Global General Anesthetics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market General Anesthetics Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global General Anesthetics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of General Anesthetics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of General Anesthetics, Product Type & Application Table 14. Global General Anesthetics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global General Anesthetics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Eisai Company Information Table 19. Eisai Business Overview Table 20. Eisai General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Eisai General Anesthetics Product Portfolio Table 22. Eisai Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson General Anesthetics Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Merck Company Information Table 29. Merck Business Overview Table 30. Merck General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Merck General Anesthetics Product Portfolio Table 32. Merck Recent Developments Table 33. Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information Table 34. Jiangsu Hengrui Pharmaceutical Co., Ltd. Business Overview Table 35. Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Product Portfolio Table 37. Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Developments Table 38. GlaxoSmithKline Company Information Table 39. GlaxoSmithKline Business Overview Table 40. GlaxoSmithKline General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. GlaxoSmithKline General Anesthetics Product Portfolio Table 42. GlaxoSmithKline Recent Developments Table 43. Fresenius Kabi AG Company Information Table 44. Fresenius Kabi AG Business Overview Table 45. Fresenius Kabi AG General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Fresenius Kabi AG General Anesthetics Product Portfolio Table 47. Fresenius Kabi AG Recent Developments Table 48. Baxter International Company Information Table 49. Baxter International Business Overview Table 50. Baxter International General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Baxter International General Anesthetics Product Portfolio Table 52. Baxter International Recent Developments Table 53. AbbVie Company Information Table 54. AbbVie Business Overview Table 55. AbbVie General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. AbbVie General Anesthetics Product Portfolio Table 57. AbbVie Recent Developments Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. AstraZeneca General Anesthetics Product Portfolio Table 62. AstraZeneca Recent Developments Table 63. Lannett Company Information Table 64. Lannett Business Overview Table 65. Lannett General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Lannett General Anesthetics Product Portfolio Table 67. Lannett Recent Developments Table 68. Hikma Pharmaceuticals Company Information Table 69. Hikma Pharmaceuticals Business Overview Table 70. Hikma Pharmaceuticals General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Hikma Pharmaceuticals General Anesthetics Product Portfolio Table 72. Hikma Pharmaceuticals Recent Developments Table 73. Endo International Company Information Table 74. Endo International Business Overview Table 75. Endo International General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Endo International General Anesthetics Product Portfolio Table 77. Endo International Recent Developments Table 78. Boehringer Ingelheim Company Information Table 79. Boehringer Ingelheim Business Overview Table 80. Boehringer Ingelheim General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim General Anesthetics Product Portfolio Table 82. Boehringer Ingelheim Recent Developments Table 83. B. Braun Melsungen AG Company Information Table 84. B. Braun Melsungen AG Business Overview Table 85. B. Braun Melsungen AG General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. B. Braun Melsungen AG General Anesthetics Product Portfolio Table 87. B. Braun Melsungen AG Recent Developments Table 88. Aspen Pharmacare Company Information Table 89. Aspen Pharmacare Business Overview Table 90. Aspen Pharmacare General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Aspen Pharmacare General Anesthetics Product Portfolio Table 92. Aspen Pharmacare Recent Developments Table 93. Abbott Laboratories Company Information Table 94. Abbott Laboratories Business Overview Table 95. Abbott Laboratories General Anesthetics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Abbott Laboratories General Anesthetics Product Portfolio Table 97. Abbott Laboratories Recent Developments Table 98. Global General Anesthetics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global General Anesthetics Sales by Region (2021-2026) & (k units) Table 100. Global General Anesthetics Sales Market Share by Region (2021-2026) Table 101. Global General Anesthetics Sales by Region (2027-2032) & (k units) Table 102. Global General Anesthetics Sales Market Share by Region (2027-2032) Table 103. Global General Anesthetics Revenue by Region (2021-2026) & (US$ Million) Table 104. Global General Anesthetics Revenue Market Share by Region (2021-2026) Table 105. Global General Anesthetics Revenue by Region (2027-2032) & (US$ Million) Table 106. Global General Anesthetics Revenue Market Share by Region (2027-2032) Table 107. North America General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America General Anesthetics Sales by Country (2021-2026) & (k units) Table 109. North America General Anesthetics Sales by Country (2027-2032) & (k units) Table 110. North America General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 111. North America General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe General Anesthetics Sales by Country (2021-2026) & (k units) Table 114. Europe General Anesthetics Sales by Country (2027-2032) & (k units) Table 115. Europe General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific General Anesthetics Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific General Anesthetics Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 122. South America General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America General Anesthetics Sales by Country (2021-2026) & (k units) Table 124. South America General Anesthetics Sales by Country (2027-2032) & (k units) Table 125. South America General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 126. South America General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa General Anesthetics Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa General Anesthetics Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 132. Global General Anesthetics Sales by Type (2021-2026) & (k units) Table 133. Global General Anesthetics Sales by Type (2027-2032) & (k units) Table 134. Global General Anesthetics Sales Market Share by Type (2021-2026) Table 135. Global General Anesthetics Sales Market Share by Type (2027-2032) Table 136. Global General Anesthetics Revenue by Type (2021-2026) & (US$ Million) Table 137. Global General Anesthetics Revenue by Type (2027-2032) & (US$ Million) Table 138. Global General Anesthetics Revenue Market Share by Type (2021-2026) Table 139. Global General Anesthetics Revenue Market Share by Type (2027-2032) Table 140. Global General Anesthetics Price by Type (2021-2026) & (US$/unit) Table 141. Global General Anesthetics Price by Type (2027-2032) & (US$/unit) Table 142. Global General Anesthetics Sales by Application (2021-2026) & (k units) Table 143. Global General Anesthetics Sales by Application (2027-2032) & (k units) Table 144. Global General Anesthetics Sales Market Share by Application (2021-2026) Table 145. Global General Anesthetics Sales Market Share by Application (2027-2032) Table 146. Global General Anesthetics Revenue by Application (2021-2026) & (US$ Million) Table 147. Global General Anesthetics Revenue by Application (2027-2032) & (US$ Million) Table 148. Global General Anesthetics Revenue Market Share by Application (2021-2026) Table 149. Global General Anesthetics Revenue Market Share by Application (2027-2032) Table 150. Global General Anesthetics Price by Application (2021-2026) & (US$/unit) Table 151. Global General Anesthetics Price by Application (2027-2032) & (US$/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. General Anesthetics Distributors List Table 155. General Anesthetics Customers List Table 156. General Anesthetics Industry Trends Table 157. General Anesthetics Industry Drivers Table 158. General Anesthetics Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. General Anesthetics Product Image Figure 5. Global General Anesthetics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global General Anesthetics Market Size (2021-2032) & (US$ Million) Figure 7. Global General Anesthetics Sales (2021-2032) & (k units) Figure 8. Global General Anesthetics Average Price (US$/unit) & (2021-2032) Figure 9. Inhalation Anesthestic Product Image Figure 10. Intravenous Anesthestic Product Image Figure 11. Hospital Product Image Figure 12. Ambulatory Surgery Center Product Image Figure 13. Others Product Image Figure 14. Global General Anesthetics Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of General Anesthetics, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 General Anesthetics Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global General Anesthetics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global General Anesthetics Sales by Region in 2025 Figure 20. Global General Anesthetics Revenue by Region in 2025 Figure 21. North America General Anesthetics Market Size by Country in 2025 Figure 22. North America General Anesthetics Sales Market Share by Country (2021-2032) Figure 23. North America General Anesthetics Revenue Market Share by Country (2021-2032) Figure 24. United States General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe General Anesthetics Market Size by Country in 2025 Figure 28. Europe General Anesthetics Sales Market Share by Country (2021-2032) Figure 29. Europe General Anesthetics Revenue Market Share by Country (2021-2032) Figure 30. Germany General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific General Anesthetics Market Size by Country in 2025 Figure 41. Asia Pacific General Anesthetics Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific General Anesthetics Revenue Market Share by Country (2021-2032) Figure 43. China General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America General Anesthetics Market Size by Country in 2025 Figure 52. South America General Anesthetics Sales Market Share by Country (2021-2032) Figure 53. South America General Anesthetics Revenue Market Share by Country (2021-2032) Figure 54. Brazil General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa General Anesthetics Market Size by Country in 2025 Figure 59. Middle East and Africa General Anesthetics Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa General Anesthetics Revenue Market Share by Country (2021-2032) Figure 61. Egypt General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global General Anesthetics Sales Market Share by Type (2021-2032) Figure 67. Global General Anesthetics Revenue Market Share by Type (2021-2032) Figure 68. Global General Anesthetics Price (US$/unit) by Type (2021-2032) Figure 69. Global General Anesthetics Sales Market Share by Application (2021-2032) Figure 70. Global General Anesthetics Revenue Market Share by Application (2021-2032) Figure 71. Global General Anesthetics Price (US$/unit) by Application (2021-2032) Figure 72. General Anesthetics Value Chain Figure 73. General Anesthetics Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. General Anesthetics Industry Opportunities and Challenges

Scope & coverage.

Types
  • Inhalation Anesthestic
  • Intravenous Anesthestic
Applications
  • Hospital
  • Ambulatory Surgery Center
  • Others
Companies covered
  • Eisai
  • Johnson & Johnson
  • Merck
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • GlaxoSmithKline
  • Fresenius Kabi AG
  • Baxter International
  • AbbVie
  • AstraZeneca
  • Lannett
  • Hikma Pharmaceuticals
  • Endo International
  • Boehringer Ingelheim
  • B. Braun Melsungen AG
  • Aspen Pharmacare
  • Abbott Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global General Anesthetics Market Size (2021-2032)
  4. 2.2.2 Global General Anesthetics Sales (2021-2032)
  5. 2.2.3 Global General Anesthetics Market Average Price (2021-2032)
  6. 2.3 General Anesthetics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Inhalation Anesthestic
  9. 2.3.3 Intravenous Anesthestic
  10. 2.4 General Anesthetics by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Ambulatory Surgery Center
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global General Anesthetics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global General Anesthetics Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global General Anesthetics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global General Anesthetics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global General Anesthetics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of General Anesthetics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of General Anesthetics, Product Type & Application
  8. 3.8 Global Manufacturers of General Anesthetics, Established Date
  9. 3.9 Global General Anesthetics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Eisai
  2. 4.1.1 Eisai Company Information
  3. 4.1.2 Eisai Business Overview
  4. 4.1.3 Eisai General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Eisai General Anesthetics Product Portfolio
  6. 4.1.5 Eisai Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson General Anesthetics Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Merck
  14. 4.3.1 Merck Company Information
  15. 4.3.2 Merck Business Overview
  16. 4.3.3 Merck General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck General Anesthetics Product Portfolio
  18. 4.3.5 Merck Recent Developments
  19. 4.4 Jiangsu Hengrui Pharmaceutical Co., Ltd.
  20. 4.4.1 Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Jiangsu Hengrui Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Product Portfolio
  24. 4.4.5 Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 GlaxoSmithKline
  26. 4.5.1 GlaxoSmithKline Company Information
  27. 4.5.2 GlaxoSmithKline Business Overview
  28. 4.5.3 GlaxoSmithKline General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 GlaxoSmithKline General Anesthetics Product Portfolio
  30. 4.5.5 GlaxoSmithKline Recent Developments
  31. 4.6 Fresenius Kabi AG
  32. 4.6.1 Fresenius Kabi AG Company Information
  33. 4.6.2 Fresenius Kabi AG Business Overview
  34. 4.6.3 Fresenius Kabi AG General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Fresenius Kabi AG General Anesthetics Product Portfolio
  36. 4.6.5 Fresenius Kabi AG Recent Developments
  37. 4.7 Baxter International
  38. 4.7.1 Baxter International Company Information
  39. 4.7.2 Baxter International Business Overview
  40. 4.7.3 Baxter International General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Baxter International General Anesthetics Product Portfolio
  42. 4.7.5 Baxter International Recent Developments
  43. 4.8 AbbVie
  44. 4.8.1 AbbVie Company Information
  45. 4.8.2 AbbVie Business Overview
  46. 4.8.3 AbbVie General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 AbbVie General Anesthetics Product Portfolio
  48. 4.8.5 AbbVie Recent Developments
  49. 4.9 AstraZeneca
  50. 4.9.1 AstraZeneca Company Information
  51. 4.9.2 AstraZeneca Business Overview
  52. 4.9.3 AstraZeneca General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 AstraZeneca General Anesthetics Product Portfolio
  54. 4.9.5 AstraZeneca Recent Developments
  55. 4.10 Lannett
  56. 4.10.1 Lannett Company Information
  57. 4.10.2 Lannett Business Overview
  58. 4.10.3 Lannett General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Lannett General Anesthetics Product Portfolio
  60. 4.10.5 Lannett Recent Developments
  61. 4.11 Hikma Pharmaceuticals
  62. 4.11.1 Hikma Pharmaceuticals Company Information
  63. 4.11.2 Hikma Pharmaceuticals Business Overview
  64. 4.11.3 Hikma Pharmaceuticals General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hikma Pharmaceuticals General Anesthetics Product Portfolio
  66. 4.11.5 Hikma Pharmaceuticals Recent Developments
  67. 4.12 Endo International
  68. 4.12.1 Endo International Company Information
  69. 4.12.2 Endo International Business Overview
  70. 4.12.3 Endo International General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Endo International General Anesthetics Product Portfolio
  72. 4.12.5 Endo International Recent Developments
  73. 4.13 Boehringer Ingelheim
  74. 4.13.1 Boehringer Ingelheim Company Information
  75. 4.13.2 Boehringer Ingelheim Business Overview
  76. 4.13.3 Boehringer Ingelheim General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Boehringer Ingelheim General Anesthetics Product Portfolio
  78. 4.13.5 Boehringer Ingelheim Recent Developments
  79. 4.14 B. Braun Melsungen AG
  80. 4.14.1 B. Braun Melsungen AG Company Information
  81. 4.14.2 B. Braun Melsungen AG Business Overview
  82. 4.14.3 B. Braun Melsungen AG General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 B. Braun Melsungen AG General Anesthetics Product Portfolio
  84. 4.14.5 B. Braun Melsungen AG Recent Developments
  85. 4.15 Aspen Pharmacare
  86. 4.15.1 Aspen Pharmacare Company Information
  87. 4.15.2 Aspen Pharmacare Business Overview
  88. 4.15.3 Aspen Pharmacare General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Aspen Pharmacare General Anesthetics Product Portfolio
  90. 4.15.5 Aspen Pharmacare Recent Developments
  91. 4.16 Abbott Laboratories
  92. 4.16.1 Abbott Laboratories Company Information
  93. 4.16.2 Abbott Laboratories Business Overview
  94. 4.16.3 Abbott Laboratories General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Abbott Laboratories General Anesthetics Product Portfolio
  96. 4.16.5 Abbott Laboratories Recent Developments
5 Global General Anesthetics Market Scenario by Region
  1. 5.1 Global General Anesthetics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global General Anesthetics Sales by Region: 2021-2032
  3. 5.2.1 Global General Anesthetics Sales by Region: 2021-2026
  4. 5.2.2 Global General Anesthetics Sales by Region: 2027-2032
  5. 5.3 Global General Anesthetics Revenue by Region: 2021-2032
  6. 5.3.1 Global General Anesthetics Revenue by Region: 2021-2026
  7. 5.3.2 Global General Anesthetics Revenue by Region: 2027-2032
  8. 5.4 North America General Anesthetics Market Facts & Figures by Country
  9. 5.4.1 North America General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America General Anesthetics Sales by Country (2021-2032)
  11. 5.4.3 North America General Anesthetics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe General Anesthetics Market Facts & Figures by Country
  16. 5.5.1 Europe General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe General Anesthetics Sales by Country (2021-2032)
  18. 5.5.3 Europe General Anesthetics Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific General Anesthetics Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific General Anesthetics Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific General Anesthetics Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America General Anesthetics Market Facts & Figures by Country
  41. 5.7.1 South America General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America General Anesthetics Sales by Country (2021-2032)
  43. 5.7.3 South America General Anesthetics Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa General Anesthetics Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa General Anesthetics Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa General Anesthetics Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global General Anesthetics Sales by Type (2021-2032)
  2. 6.1.1 Global General Anesthetics Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global General Anesthetics Sales Market Share by Type (2021-2032)
  4. 6.2 Global General Anesthetics Revenue by Type (2021-2032)
  5. 6.2.1 Global General Anesthetics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global General Anesthetics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global General Anesthetics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global General Anesthetics Sales by Application (2021-2032)
  2. 7.1.1 Global General Anesthetics Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global General Anesthetics Sales Market Share by Application (2021-2032)
  4. 7.2 Global General Anesthetics Revenue by Application (2021-2032)
  5. 7.2.1 Global General Anesthetics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global General Anesthetics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global General Anesthetics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 General Anesthetics Value Chain Analysis
  2. 8.1.1 General Anesthetics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 General Anesthetics Production Mode & Process
  5. 8.2 General Anesthetics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 General Anesthetics Distributors
  8. 8.2.3 General Anesthetics Customers
9 Global General Anesthetics Analyzing Market Dynamics
  1. 9.1 General Anesthetics Industry Trends
  2. 9.2 General Anesthetics Industry Drivers
  3. 9.3 General Anesthetics Industry Opportunities and Challenges
  4. 9.4 General Anesthetics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst